Stem Cell Transplants of Greatest Benefit to RMS Patients at Earlier Disease Stages, Study Says
Stem cell transplants are most effective if done in young multiple sclerosis (MS) patients in early disease stages, who have not gone…
Articles by Patricia Silva, PhD
Ozanimod Reduces Multiple Sclerosis Relapse Rate, Phase 3 Trial Shows
A Phase 3 clinical trial evaluating the safety and effectiveness of ozanimod (RPC-1063) in patients with relapsing multiple sclerosis (RMS) shows…
Fitness Trainer and MS Patient, Dolly Stokes, Launch BFitLifestyles Website with Husband
Dolly Stokes, a fitness trainer and multiple sclerosis (MS) patient, and her husband, Jeff Stokes, have launched the website for their fitness…
BpiFrance Awards PathMaker Grant to Develop MyoRegulator, Device to Treat Spasticity
The French economic promotion agency Bpifrance has awarded Boston-based PathMaker Neurosystems a grant to finance the development of its MyoRegulator, a noninvasive neurotherapy technology to…
AARDA Launches Registry to Help Link MS Patients, Researchers
The world’s first registry for patients with multiple sclerosis (MS) and other autoimmune diseases (ADs) has gone online, to honor National Autoimmune…
FDA OKs Bioness’ Electrical-stimulation Rehabilitation Device for Gait Impairment
The U.S. Food and Drug Administration (FDA) has authorized the use of Bioness’ L300 Go System electrical-stimulation rehabilitation device for…
New Compound, ST266, May Prevent Optic Neuritis Linked to Multiple Sclerosis
Researchers have tested a new compound called ST266 in a mouse model of multiple sclerosis (MS) and found that its anti-inflammatory…
Cladribine Tablets Reduce Brain Atrophy in MS Patients, Merck Study Finds
EMD Soreno has recently published Phase 3 clinical data showing that Cladribine tablets reduced the annualized rate of brain volume…
Tongue Stimulation Could Give MS Patients Better Rehabilitation Outcomes, Study Suggests
Multiple sclerosis (MS) patients given gentle electrical stimulation to their tongues during physical and cognitive rehabilitation training benefited more than those…
LiveWiseMS: A New Online Resource for People Living with MS
A new online resource, LiveWiseMS.org, aims to raise awareness about multiple sclerosis (MS) and provide patients and caregivers information about the…
Regular Massage Therapy Eases Pain and Fatigue of MS, Small Study Reports
Regular massage therapy given people with multiple sclerosis (MS) significantly reduced their pain and fatigue, and helped to ease spasticity, a small…
Shoe Insoles Meant to Make Walking Easier for MS Patients to Be Tested in Australia
A specialty shoe insole that may help multiple sclerosis (MS) patients walk and go about their daily lives with more assurance…
First Multiple Sclerosis Blood Biomarker Discovered; Test May Soon Be Available
Scientists have discovered the first blood biomarker for multiple sclerosis (MS) – a chemical identifier in the blood. The discovery should…
Removing Barriers to Accessibility Requires Planning, Persistence
Lost in the delights…
95% of MS Patients Open to Marijuana Treatment, 73% Have Tried It
Ninety-five percent of multiple sclerosis (MS) patients believe medical marijuana should be a treatment option, according to a GeneFo online survey. The…
How MS Patients Judge Their Treatments Differs from Doctors’ Views, Study Reports
Considerable differences exist in how multiple sclerosis patients, healthcare providers and insurance companies assess the value of current MS treatments,…
Clinical Trial Supports Stem Cell Transplants to Treat RMS Patients with High Disease Activity
A newly concluded clinical trial gives scientific evidence of the benefits that a stem cell transplant holds for multiple sclerosis (MS) patients who fail…
New tDCS Devices May Boost Cognition in MS — But Don’t Use One at Home Without Guidance
Multiple sclerosis (MS) patients who received transcranial direct current stimulation (tDCS) while playing brain-training video games improved their learning and…
Nasal Solution Made of ‘Molecular Soup’ Protects Eye Neurons in MS Mice with Optic Neuritis
A treatment delivered as a nasal solution helped to preserve eye neurons and improve eyesight in a mouse model of multiple sclerosis…
Patient Opinions on Zinbryta Seen to Match Phase 3 Trial Data, Supporting Questionnaire Use
More relapsing multiple sclerosis (MS) patients treated with Zinbryta (daclizumab) said they felt its health benefits than did those given Avonex (interferon beta-1a) — demonstrating that…
Tennessee Neurologist to Lead $8.4M MS Research Program at University of Saskatchewan
The University of Saskatchewan‘s incoming Chair in Multiple Sclerosis Clinical Research will have a research endowment worth $8.4 million to help…
Flex Pharma Shifts Focus to Programs Targeting MS, Other Neurological Diseases
Flex Pharma said it plans to prioritize developing its clinical programs in neurological diseases, including multiple sclerosis (MS), amyotrophic lateral…
Genes That Influence Physical Traits May Be Reason MS More Common in Women
The key to why more women than men develop multiple sclerosis (MS) may be genes that influence physical traits, such…
PathMaker, French Institute to Team on MyoRegulator Neuro-stimulation Clinical Trials
PathMaker Neurosystems and the Brain and Spine Institute (ICM) in Paris will collaborate on human clinical trials to secure…
University of Maryland and VA to Investigate Tregs as Possible MS Treatment
The VA Maryland Health Care System (VAMHCS) and the University of Maryland Fischell Department of Bioengineering are collaborating in a…
MS Researcher at Cleveland Clinic Awarded $7M to Pursue Ways of Stopping Myelin Damage
Two Cleveland Clinic researchers were awarded multi-year grants by the National Institutes of Health (NIH), under its Outstanding Investigator Award, to find…
Astrocytes Can Turn Aggressive and Kill Neurons, Potentially Groundbreaking Study Says
In what may be one of the most significant discoveries in neurodegenerative disease, researchers have found that brain cells, called astrocytes,…
MS Patients with Spasticity Needed for Study of Extended-release Baclofen Capsules
A new clinical trial evaluating the effectiveness of extended-release baclofen capsules in relieving spasticity related to multiple sclerosis (MS) is calling…
Siemens Healthineers and Biogen to Enhance MRI’s Ability to Help MS Patients
Siemens Healthineers and Biogen will collaborate to develop new magnetic resonance imaging (MRI) applications that can quantify key markers…
Reports on MS Treatment Market Show Growing Shift to Oral Therapies
The multiple sclerosis (MS) market shifted during 2016, with oral disease-modifying therapies (DMTs) capturing a greater share and Sanofi-Genzyme’s Aubagio…